ABYRX is a leading brand in surgical therapeutic devices. Since its inception in 2013, ABYRX has been at the forefront of innovation in the medical field. The company acquired the HEMASORB Resorbable Hemostatic Bone Putty portfolio, along with the rights to develop Bezwada Biomedical's polymer technology for bone applications.

ABYRX specializes in the development, manufacturing, and provision of advanced biomaterials and therapeutic devices used during surgical procedures. With a commitment to revolutionizing the surgical experience, ABYRX strives to provide cutting-edge solutions that enhance patient outcomes. Headquartered in Stamford, CT, ABYRX is a privately-held company with a strong focus on research and development.

Their dedication to innovation is evident in their extensive portfolio of patented products, with over 50 issued and pending patents. When it comes to surgical and therapeutic devices, ABYRX is a trusted name in the industry, offering reliable and effective solutions for healthcare professionals worldwide. With a firm belief in the power of advanced biomaterials, ABYRX is driving progress in surgical procedures and redefining the future of healthcare